Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

January 3, 2017 by Alan Khadavi

Does Xolair Work for Eczema?

Does Xolair work for eczema?  Is a question that has been asked by many atopic dermatitis sufferers since the drug came out.  Omalizumab targets IgE and many patients with eczema have extremely high levels of IgE.  The only problem is that it approved for patients who have asthma whose IgE go up to 700 IU/ml, many eczema sufferers have IgE levels in the thousands range.  Nevertheless, a study was done in Taiwan published in the Journal of Allergy and Clinical Immunology titled “Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis” to see if it works.

A total of 15 studies were pooled together, over 100 patients with eczema were identified, most of the patients (60%) had severe atopic dermatitis.  Only 25% of the population had serum IgE values less than 700 IU/ml and 43% of patients showed IgE concentrations above 5000 IU/ml.  Also 67% of the patients with eczema were treated with 600 mg or more of Xolair per month.

Results showed:

43% of those with eczema achieved excellent clinical response

27% showed satisfying results

30% showed irrelevant clinical changes or even deterioration

The patients whose IgE concentration of lower than 700 IU/ml were significantly associated with an excellent clinical response.

More than likely, the patients who have a very high IgE level would benefit more if the Xolair dosage was increased, but there are no current studies supporting that.  Some patients had IgE levels greater than 5000 IU/ml and if they only received 300mg injection of Xolair, that probably is not enough to suppress the IgE levels in the serum.  The patients who had severe eczema with lower IgE levels, showed greater benefit with Xolair injections.

There is no recommended dosage for patients whose pretreatment serum total IgE concentrations or body weight outside the limits of the dosing table.  The association of serum IgE concentrations of less than 700 IU/ml with more favorable clinical responses in this analysis might be explained by better IgE neutralization in patients with lower concentrations of IgE under fixed dosages.

In conclusion, there is no concrete evidence of the overall effectiveness of Xolair (omalizumab) for atopic dermatitis (eczema).  Forty three  percent of the patients with atopic dermatitis (eczema) could achieve remarkable clinical response after Xolair treatment.  Potential therapeutic benefits might be seen in selected patients with lower serum concentrations of IgE.  The optimal dosage of Xolair for patients with eczema with higher IgE levels should be further studied.

To learn more about IgE and other potential eczema options, see below.  If you suffer from eczema, speak to an allergy specialist to see what options are best available for you.

Elevated IgE Levels

Dupixent (Dupilumab) for Atopic Dermatitis/Eczema

 

 

Filed Under: Allergy Medicine, atopic dermatitis, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page